436 results on '"Masson, Adèle"'
Search Results
2. Real-life efficacy of immunotherapy for Sézary syndrome: a multicenter observational cohort study
3. Allogeneic transplantation in advanced cutaneous T-cell lymphomas (CUTALLO): a propensity score matched controlled prospective study
4. Graft-versus-lymphoma effect in skin after allogeneic hematopoietic stem cell transplantation for Sézary syndrome
5. Macrophage-derived CXCL9 and CXCL11, T-cell skin homing, and disease control in mogamulizumab-treated CTCL patients
6. Evolution of patients with Sézary syndrome after mogamulizumab discontinuation for any cause except progression: a multicenter retrospective study (Moga-stop study)
7. Cutaneous clonal mature plasmacytoid dendritic cell dermatosis in patients with myeloid neoplasms
8. Impact of blood tumour clone frequency on time to next treatment in mycosis fungoides
9. Targeting TGF-beta activation in cutaneous T-cell lymphomas
10. Periorbital erythema and oedema revealing angioimmunoblastic T cell lymphoma
11. Mogamulizumab-induced vitiligo in patients with Sézary syndrome: three cases
12. Myopathy related to chronic Graft‐Versus‐Host Disease: From clinic to histological & immunological characterization by imaging mass cytometry.
13. Sezary syndrome revealed by PD‐L1 blockade for tumor stage mycosis fungoides.
14. Targeting CCR4 with mogamulizumab in refractory CD3-CD4+ lymphocytic-variant hypereosinophilic syndrome
15. CD39 is expressed by a wide range of cutaneous T‐cell lymphomas
16. Two cases of Dupilumab responsive Kimura disease
17. Transcriptomic Landscape of Prurigo Nodularis Lesional Skin CD3+ T Cells Using Single-Cell RNA Sequencing
18. CD30-positive anaplastic large-cell lymphoma associated with mycosis fungoides after treatment with dupilumab
19. Response to Campbell et al.’s comments on our study “Real-life efficacy of immunotherapy for Sézary syndrome: a multicenter observational cohort study”
20. Targeting TGF-β Activation in Cutaneous T-Cell Lymphomas
21. Two cases of dupilumab-responsive Kimura disease.
22. Skin involvement in systemic lymphoma of follicular helper T-cell origin: a cohort study of 57 patients
23. Primary cutaneous follicle center lymphoma with secondary systemic evolution
24. Heterogeneity of PD-L1 expression and CD8 tumor-infiltrating lymphocytes among subtypes of cutaneous adnexal carcinomas
25. Successful Treatment of Generalized Eruptive Keratoacanthoma of Grzybowski with Acitretin
26. Severe relapses of cutaneous T‐cell lymphoma after treatment of chronic graft‐versus‐host disease with ruxolitinib
27. Syndrome de Sézary.
28. Visceral leishmaniasis in patients with lymphoma: Case reports and review of the literature
29. Abstract 3644: Targeting the CD51/TGF-beta pathway: a potential innovative cancer immunotherapy in T-cell lymphomas
30. Exploring the non-lymphocytic cutaneous microenvironment in advanced cutaneous T-cell lymphomas using single-cell RNA-sequencing
31. P-205 - Toxic epidermal necrolysis possibly associated with mogamulizumab in a patient with Sézary syndrome
32. P-170 - Cutaneous manifestations of lymphoid‐variant hypereosinophilic syndrome
33. P-166 - Primary cutaneous follicle center lymphoma with secondary systemic evolution
34. O-150 - Allogeneic transplantation in advanced cutaneous T-cell lymphomas (CUTALLO): a propensity score matched controlled prospective study
35. O-129 - Skin involvement in systemic lymphoma of follicular helper T-cell origin: a cohort study of 57 patients
36. O-103 - CD38 targeting in aggressive, treatment-refractory cutaneous T-cell lymphomas
37. Primary cutaneous follicle centre lymphoma with secondary systemic evolution.
38. Mycosis Fungoides and Sézary Syndrome: Microenvironment and Cancer Progression
39. Toxic epidermal necrolysis possibly associated with mogamulizumab in a patient with Sézary syndrome
40. Trunk involvement and peau d'orange aspect are poor prognostic factors in eosinophilic fasciitis (Shulman disease): A multicenter retrospective study of 119 patients
41. CD38 targeting in aggressive, treatment-refractory cutaneous T-cell lymphomas
42. CD24hiCD27+ and plasmablast-like regulatory B cells in human chronic graft-versus-host disease
43. CD38 Targeting in Aggressive, Treatment-Refractory Cutaneous T-Cell Lymphomas
44. Chronic graft versus host disease presenting as lichen planus pigmentosus
45. eOSCE stations live versus remote evaluation and scores variability
46. Large-cell transformation is an independent poor prognostic factor in Sézary syndrome: analysis of 117 cases
47. Tumor Clone Frequency Calculation Using High-Throughput Sequencing of the TCRβ Gene in Patients with Folliculotropic Mycosis Fungoides
48. Exploring the Nonlymphocytic Cutaneous Microenvironment in Advanced Cutaneous T-Cell Lymphomas using Single-Cell RNA Sequencing
49. Severe relapses of cutaneous T‐cell lymphoma after treatment of chronic graft‐versus‐host disease with ruxolitinib.
50. Serum infliximab levels and clinical response in hidradenitis suppurativa.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.